We offer bespoke consulting to biotechs and investors, increasing the value of innovations by accelerating and broadening patient access. "Qiáo" means bridge in Mandarin. Our vision is to enable a seamless healthcare system for the benefit of patients, by building bridges between stakeholders.
Products, services, technology
Some of our bespoke services include: Comprehensive x-functional global patient access plan, Integrated evidence plan that maximizes value, bridge between global strategies and an actionable US/China/EU/JP plan. Contact us for any enquiries about patient access in general or your specific challenge.
Cooperation possibilities
We are happy to collaborate with other service providers who share our vision, as well as with investors who would like to incorporate patient access potential into their biotech/pharma valuations.
- http://www.qiaoadvisors.com
- +41 79 124 44 96
- hello@qiaoadvisors.com
- Alexandre Joyeux
Some insights
Qiáo aims to make the world a better place by ensuring that biotech innovations become accessible to patients as seamlessly as possible through active collaboration across the health care system.
I'm extremely proud of Qiáo because it will serve patient needs while also building capabilities and improving the value of biotech actors and their investors. These resources can then be reinvested in further innovations in healthcare.
Qiáo is a role model because it seeks to find win-win solutions for all actors in the healthcare system and improve collaboration for the greater benefit of patients.
We bring 20 years and 6 global product launch experience (incl. 1st gene therapy), and deep knowledge of drug development and patient access globally. We also have experience in launching rare disease treatments in China. We will seek to bring in more medical and business experience in the future.
I would love to get in contact with pharma/biotech investors and c-suite executives